Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Recent News Hurt Johnson & Johnson?
Wall St Cheat Sheet
Thursday, November 21, 2013 - 8:32am
tags:
JNJ
Aphios Spins off Amylon LLC to Develop Novel Alzheimer's Disease Drug
4-Traders.com
Thursday, November 21, 2013 - 8:29am
tags:
Aphios, Amylon, Alzheimer's disease, APH-1104
FDA declines to approve new Forest, Richter drug
Reuters
Thursday, November 21, 2013 - 8:27am
tags:
FDA, Forest Labs, Geodon Richter, cariprazine
Pfizer, Glaxo to initiate study of combination therapy in patients with melanoma
The Fly on the Wall
Thursday, November 21, 2013 - 8:25am
tags:
GSK, Pfizer, melanoma, trametinib, palbociclib
4 Biotech Stocks Spiking on Unusual Volume
TheStreet.com
Thursday, November 21, 2013 - 8:23am
tags:
Biomarin, Onconova, ANI Pharmaceuticals, Clovis Oncology
Actavis restructures its U.S. Specialty Brands sales unit
Marketwatch
Wednesday, November 20, 2013 - 5:14pm
tags:
Actavis, restructuring, layoffs, Warner Chilcott
Amicus, GlaxoSmithKline announce revised Fabry agreement
The Fly on the Wall
Wednesday, November 20, 2013 - 5:12pm
tags:
Amicus Therapeutics, Fabry's disease, GSK, Migalastat HCl
Zogenix - The 3 Main Hurdles For Zohydro
Seeking Alpha
Wednesday, November 20, 2013 - 4:39pm
tags:
Zogenix, Zohydro, chronic pain, hydrocodone
Vertex Gains on Sale of Drug Rights to Johnson & Johnson Unit
Barron's
Wednesday, November 20, 2013 - 4:37pm
tags:
Vertex Pharmaceuticals, JNJ, Incivo, Janssen, hepatitis C
A Few Dozen Here, A Few Dozen There... More Pharma Layoffs
Pharmalot
Wednesday, November 20, 2013 - 12:10pm
tags:
layoffs, Actavis, AstraZeneca, Bayer
Cholesterol Drug From Trash Seen Preventing Heart Attack
Bloomberg
Wednesday, November 20, 2013 - 11:57am
tags:
cholesterol, hemophilia, heart attack, CSL
Boston Scientific wins CE Mark, FDA nod for Direxion microcatheter
Mass Device
Wednesday, November 20, 2013 - 11:55am
tags:
Boston Scientific, FDA, Direxion, microcatheters, devices, CE Mark
One certainty: Drug spending will hit $1 trillion in 2014
Fierce Pharma
Wednesday, November 20, 2013 - 11:54am
tags:
IMS, drug spending
Breaking up with Pfizer is hard to do, Zoetis chief says, but worth it
Fierce Pharma
Wednesday, November 20, 2013 - 11:53am
tags:
Pfizer, Zoetis, animal health
Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData
The Pharma Letter
Wednesday, November 20, 2013 - 11:48am
tags:
Shire, M&A, ViroPharma
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps
Yahoo/Zacks.com
Wednesday, November 20, 2013 - 11:47am
tags:
Vanda, Sarepta Therapeutics, tasimelteon, Hetlioz, Duchenne Muscular Dystrophy, eteplirsen
FDA warns of heart risks with Astellas' Lexiscan and Adenoscan
Reuters
Wednesday, November 20, 2013 - 11:14am
tags:
FDA, Astellas, Lexiscan, Adenoscan
2 Pharmas That Should Move After 55th ASH Meeting
Seeking Alpha
Wednesday, November 20, 2013 - 11:01am
tags:
ASH, Iclusig, Ariad Pharmaceuticals, SL-401, CML, Stemline
Arthroscopy Devices Market is Expected to Reach USD 5.1 Billion Globally in 2019: Transparency Market Research
CP Wire
Wednesday, November 20, 2013 - 10:44am
tags:
arthroscopy, devices
J&J shares are helped by findings on stroke-prevention medication
Marketwatch
Wednesday, November 20, 2013 - 8:41am
tags:
JNJ, Xarelto, Janssen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.